Fundamentals of Chemotherapy
Immunotherapy Administration – Test
2025 !!
Hematologic cancer (blood cancer) - ANSWERS-cancer that begins in bone marrow or immune system cells.
-Ex: leukemia, lymphoma, multiple myeloma
Leukemia - ANSWERScancer starts in blood-forming tissues like bone marrow
-causes lots of abnormal blood cells to be produced and enter bloodstream
Lymphoma - ANSWERS-cancer that begins in immune system (WBC=lymphocytes)
-hodgkin and non-hodgkins
-B lymphocytes (B cells) - make antibodies (bacteria and viruses, most common lymphoma
-T lymphocytes (T cells) - boost/slow immune, destroy germs and abnormal cells
Hodgkin lymphoma - ANSWERSReed-Sternberg cell (cancer cells in classic)
-typically starts in B cells
Non-Hodgkin's Lymphoma - ANSWERS-large, diverse group of cancers in immune system cells
-indolent (slow growing) or aggressive (fast)
Myeloma - ANSWERSCancer in plasma cells (WBC that produce antibodies)
Chemotherapy - ANSWERSAll antineoplastic agents used to treat cancer, given through oral and parenteral
routes or other routes as specified in the standard, not including hormonal therapies.
Who can order chemotherapy? - ANSWERSWritten and signed by licensed independent practitioners (MD/DO,
PA, Oncology NP)
, Can you use verbal orders for chemotherapy? - ANSWERSNO! Only when holding/stopping admin.
Who can mix Chemotherapy? - ANSWERSPharmacist, Pharmacy tech, MD/DO, qualified RN
Who can administer chemotherapy? - ANSWERSRegistered Nurses with specialized education, prep and
training. See specific state laws and statutes
How often is chemo competency reassessed> - ANSWERSAnnual continuing ed and competency assessment is
recommended
What is the dose verification process? - ANSWERS-confirm plan with patient
-two practitioners verify: drug name, dose, volume, rate, route, expiration date, appearance
-document verification in chart
What PPE is required for IV Chemotherapy? - ANSWERS-Gloves: two pairs, HD tested
-Gown: disposable, back closed, long sleeved
-Respirator: NIOSH approved
-Eye & Face: face shield/mask
Neoadjuvant therapy (tumor burden) - ANSWERSChemo BEFORE primary treatment (common in breast and
colon)
Adjuvant therapy - ANSWERSChemo AFTER primary treatment (common in solid tumor)
Bone Marrow - ANSWERSsoft, sponge-like tissue in center of most bones, produce WBC, RBC, and platelets.
Myelosuppression - ANSWERSbone marrow activity is decreased, causing less RBC, WBC and Platelets.
Myeloablation - ANSWERSsevere myelosuppression
Immunotherapy Administration – Test
2025 !!
Hematologic cancer (blood cancer) - ANSWERS-cancer that begins in bone marrow or immune system cells.
-Ex: leukemia, lymphoma, multiple myeloma
Leukemia - ANSWERScancer starts in blood-forming tissues like bone marrow
-causes lots of abnormal blood cells to be produced and enter bloodstream
Lymphoma - ANSWERS-cancer that begins in immune system (WBC=lymphocytes)
-hodgkin and non-hodgkins
-B lymphocytes (B cells) - make antibodies (bacteria and viruses, most common lymphoma
-T lymphocytes (T cells) - boost/slow immune, destroy germs and abnormal cells
Hodgkin lymphoma - ANSWERSReed-Sternberg cell (cancer cells in classic)
-typically starts in B cells
Non-Hodgkin's Lymphoma - ANSWERS-large, diverse group of cancers in immune system cells
-indolent (slow growing) or aggressive (fast)
Myeloma - ANSWERSCancer in plasma cells (WBC that produce antibodies)
Chemotherapy - ANSWERSAll antineoplastic agents used to treat cancer, given through oral and parenteral
routes or other routes as specified in the standard, not including hormonal therapies.
Who can order chemotherapy? - ANSWERSWritten and signed by licensed independent practitioners (MD/DO,
PA, Oncology NP)
, Can you use verbal orders for chemotherapy? - ANSWERSNO! Only when holding/stopping admin.
Who can mix Chemotherapy? - ANSWERSPharmacist, Pharmacy tech, MD/DO, qualified RN
Who can administer chemotherapy? - ANSWERSRegistered Nurses with specialized education, prep and
training. See specific state laws and statutes
How often is chemo competency reassessed> - ANSWERSAnnual continuing ed and competency assessment is
recommended
What is the dose verification process? - ANSWERS-confirm plan with patient
-two practitioners verify: drug name, dose, volume, rate, route, expiration date, appearance
-document verification in chart
What PPE is required for IV Chemotherapy? - ANSWERS-Gloves: two pairs, HD tested
-Gown: disposable, back closed, long sleeved
-Respirator: NIOSH approved
-Eye & Face: face shield/mask
Neoadjuvant therapy (tumor burden) - ANSWERSChemo BEFORE primary treatment (common in breast and
colon)
Adjuvant therapy - ANSWERSChemo AFTER primary treatment (common in solid tumor)
Bone Marrow - ANSWERSsoft, sponge-like tissue in center of most bones, produce WBC, RBC, and platelets.
Myelosuppression - ANSWERSbone marrow activity is decreased, causing less RBC, WBC and Platelets.
Myeloablation - ANSWERSsevere myelosuppression
